Hayashi J - Search Results

1

Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response.

Furusyo N, Murata M, Ogawa E, Toyoda K, Ihara T, Ikezaki H, Hayashi T, Koga T, Kainuma M, Hayashi J. Furusyo N, et al. Among authors: hayashi j, hayashi t. J Antimicrob Chemother. 2011 May;66(5):1127-39. doi: 10.1093/jac/dkr034. Epub 2011 Feb 22. J Antimicrob Chemother. 2011. PMID: 21393126

2

Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.

Hayashi J, Kajiyama W, Noguchi A, Nakashima K, Hirata M, Hayashi S, Kashiwagi S. Hayashi J, et al. Among authors: hayashi s. Gastroenterol Jpn. 1991 Dec;26(6):742-6. doi: 10.1007/BF02782862. Gastroenterol Jpn. 1991. PMID: 1765247

3

Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.

Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Ohmiya M, Tani Y, Ikematsu H, Kashiwagi S. Hayashi J, et al. Dig Dis Sci. 1995 Aug;40(8):1837-41. doi: 10.1007/BF02212710. Dig Dis Sci. 1995. PMID: 7648988

4

A preliminary study of retreatment of chronic hepatitis C with interferon.

Kishihara Y, Hayashi J, Ohmiya M, Nakashima K, Ikematsu H, Kashiwagi S. Kishihara Y, et al. Among authors: hayashi j. Fukuoka Igaku Zasshi. 1995 Apr;86(4):113-20. Fukuoka Igaku Zasshi. 1995. PMID: 7782023 Clinical Trial.

5

Increased lactic dehydrogenase (LDH)-linked immunoglobulin associated with interferon-alpha therapy in a case of chronic hepatitis C.

Nabeshima S, Hayashi J, Hirata M, Nakashima K, Noguchi A, Kashiwagi S. Nabeshima S, et al. Among authors: hayashi j. Intern Med. 1994 Jul;33(7):446-9. doi: 10.2169/internalmedicine.33.446. Intern Med. 1994. PMID: 7949647 Free article.

6

A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C.

Hayashi J, Ohmiya M, Kishihara Y, Tani Y, Kinukawa N, Ikematsu H, Kashiwagi S. Hayashi J, et al. Am J Gastroenterol. 1994 Dec;89(12):2151-6. Am J Gastroenterol. 1994. PMID: 7977232 Clinical Trial.

7

Effectiveness of relative low-dose interferon treatment for patients with chronic hepatitis C.

Hayashi J, Kishihara Y, Tani Y, Yamaji K, Nakashima K, Ikematsu H, Kashiwagi S. Hayashi J, et al. Fukuoka Igaku Zasshi. 1994 Jul;85(7):211-8. Fukuoka Igaku Zasshi. 1994. PMID: 8070751

8

Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon.

Yoshimura E, Hayashi J, Kishihara Y, Yamaji K, Kinukawa N, Kashiwagi S. Yoshimura E, et al. Among authors: hayashi j. Dig Dis Sci. 1996 Jan;41(1):155-60. doi: 10.1007/BF02208598. Dig Dis Sci. 1996. PMID: 8565749

9

IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.

Kishihara Y, Hayashi J, Yoshimura E, Yamaji K, Nakashima K, Kashiwagi S. Kishihara Y, et al. Among authors: hayashi j. Dig Dis Sci. 1996 Feb;41(2):315-21. doi: 10.1007/BF02093821. Dig Dis Sci. 1996. PMID: 8601375

10

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection.

Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. Hayashi J, et al. Hepatology. 1997 Mar;25(3):697-701. doi: 10.1002/hep.510250334. Hepatology. 1997. PMID: 9049221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,356 results

Search Page

Filters